Evaluation of DD-25 Topical Cream for the Treatment of Psoriasis Vulgaris : Proof of Concept Study
Status:
Unknown status
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of DD-25, a new topical drug, on
plaque Psoriasis Vulgaris.
The study will include subjects at plaque stage from 5-20% body area involvement. A total of
30 subjects will be treated with cream application on affected areas twice daily for three
weeks.The efficacy of the preparation will be documented by PASI score, Global physician
assessment and photos.